Selective Blockade of Vascular Endothelial Growth Factor Receptor 2 With an Antibody Against Tumor-Derived Vascular Endothelial Growth Factor Controls the Growth of Human Pancreatic Adenocarcinoma Xenografts - Concepedia

Concepedia

Publication | Closed Access

Selective Blockade of Vascular Endothelial Growth Factor Receptor 2 With an Antibody Against Tumor-Derived Vascular Endothelial Growth Factor Controls the Growth of Human Pancreatic Adenocarcinoma Xenografts

28

Citations

36

References

2006

Year

Shane E. Holloway, Adam W. Beck, Latha Shivakumar, Jessica G. Shih, Jason B. Fleming, Rolf A. Brekken

Annals of Surgical Oncology

Selective BlockadeAngiogenesisPancreatic CancerImmunologyPathologyVascular BiologyMedicineCancer GrowthCancer ResearchTumor MicroenvironmentTumor Biology

References

	Year	Citations

Page 1